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ORIGINAL ARTICLE
The small intestine is the most difficult part of
the gastrointestinal tract to evaluate because of its
length and overlapping bowel loops. Capsule en-
doscopy allows for direct visualization of the entire
length of the small bowel in a noninvasive manner,
and it has become the main standard for evaluat-
ing suspected disease of the small intestine.1–3
The investigation of small bowel tumors has
long been a challenge. Small bowel barium radi-
ology has disappointing diagnostic yields and
push enteroscopy allows examination of only the
proximal small intestine. However, the develop-
ment of capsule endoscopy has allowed exami-
nation of the entire small intestine safely and
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Background/Purpose: Capsule endoscopy is a highly sensitive method for the detection of small bowel
lesions. False-positive findings are important confounding factors. This study reports on a scoring system
for evaluating the role of capsule endoscopy in small bowel tumors.
Methods: Ten men and two women (age, 23–79 years) with suspected small bowel tumors were included
from 120 patients referred for capsule endoscopy between March 2004 and March 2008. The indications
were gastrointestinal bleeding (n = 9), melanoma workup (n = 1), physical checkup (n = 1), and iron defi-
ciency anemia (n = 1). The proposed tumor score was composed of five components: bleeding, mucosal
disruption, an irregular surface, color, and white villi. These can be scored for probability of mass lesions
seen at capsule endoscopy. Small bowel mass lesions were probably present in those with a score of ≥ 4,
and a score of ≤ 2 indicated a low probability of a small bowel mass lesion.
Results: Capsule endoscopy showed probable small bowel mass lesions in six patients, and a low lesion
probability in the other six. Capsule endoscopy showed that new lesions were not detected by esopha-
gogastroduodenoscopy or colonoscopy. All six patients with probable small bowel tumors were found 
to have pathological findings upon capsule endoscopy: two with lymphangioma, and one each with ileal
ectopic pancreas, with melanoma metastasis, gastrointestinal lymphoma, and gastrointestinal stromal
tumor.
Conclusion: Capsule endoscopy may detect small bowel tumors more reliably by using the scoring system
outlined. It should be considered in suspected cases of small bowel tumor. [J Formos Med Assoc 2009;
108(7):533–538]
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noninvasively. Diagnostic yield is superior to
that of push enteroscopy and it leads to improved
patient outcomes.4
As a result of a lack of controlled trials, 
there is no current consensus regarding the diag-
nostic approach for attempting to reduce the 
rate of false-positive capsule endoscopy. This re-
port describes a scoring system for evaluating 
the role of capsule endoscopy in small bowel 
tumors.
Patients and Methods
A retrospective study was performed on 120 pa-
tients who underwent capsule endoscopy (Given
Imaging Ltd., Yoqneam, Israel) between March
2004 and March 2008. Clinical and other data
were collected and evaluated retrospectively. A
mass was defined by the following morphologi-
cal criteria: (1) a clearly-defined boundary with
the surrounding mucosa; (2) height larger than
the diameter; (3) a visible lumen in the frames in
which it appeared; and (4) an image lasting more
than 10 minutes. The following can be misdiag-
nosed as a small bowel mass lesion: intestinal
contraction, a normal extrinsic organ or another
small bowel loop, or intussusception. Twelve pa-
tients were included because of suspected small
bowel mass lesions. There were 10 men and two
women, with a mean age of 55.3 years (range,
23–79 years). All patients had undergone at least
one endoscopy and colonoscopy prior to capsule
endoscopy. All patients gave written informed
consent.
All patients ingested the capsule after an over-
night fast of 12 hours. Patients were allowed to
drink 2 hours after ingesting the capsule and to
eat a light meal 4 hours later. Patients were free
to leave the endoscopy department, with instruc-
tions to return 7–8 hours after ingestion to have
the recorder disconnected. The recorded infor-
mation was downloaded onto a computer, and
images from the stomach and the small bowel
were analyzed using RAPID 3 software (Given
Imaging Ltd., Yoqneam, Israel). The intestinal
transit time was calculated from the first view of
the duodenum up to the cecum. The proposed
tumor score was composed of five components:
bleeding, mucosal disruption, an irregular surface,
color, and white villi. These components can be
scored for probability of mass lesions seen at
capsule endoscopy.
Results
In this retrospective study, 12 patients with sus-
pected small bowel mass lesions out of 120 pa-
tients who were referred for capsule endoscopy
were examined using the scoring system. The find-
ings are summarized in Table 1. Esophagogastro-
duodenoscopy and colonoscopy results showed
that patient 7 did not have any abnormalities.
This patient presented with intermittent, dark
bloody stools for 2 months, accompanied by
epigastric pain and postprandial abdominal full-
ness. Capsule endoscopy revealed a small red
polyp in the ileum. Abdominal computed to-
mography (CT) and small bowel barium follow-
through were not of any help. Gastrointestinal
bleeding and abdominal discomfort were re-
solved after the lesion was removed surgically.
Pathological examination demonstrated pancre-
atic acinar cells and a secretory duct in the ileal
submucosa, which was consistent with ectopic
pancreas. Patient 10 was found to have extensive
small bowel mucosal lesions by capsule endo-
scopy. However, his earlier serial examinations—
esophagogastroduodenoscopy, colonoscopy, small
bowel series, CT and angiography—failed to dis-
close the source of bleeding. The final diagnosis
of diffuse large B cell lymphoma was established
by histology and immunohistochemical studies
of a biopsy specimen by push enteroscopy. This
patient was treated with systemic chemotherapy
and at the time of writing remains in complete
remission.
In patients 1, 2, 4 and 11, a decreased likeli-
hood of small bowel tumors was diagnosed be-
cause of as the absence of abdominal pain, weight
loss, or small bowel obstruction during follow-up.
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In patient 8, double balloon enteroscopy find-
ings were unremarkable. In patient 12, no tumor
was found during operation.
The features of the scoring system observed in
the patients are summarized in Table 2. There were
probable small bowel mass lesions in those with
a score of ≥ 4 (Figure 1). The etiology was lym-
phangioma in two patients, and ileal ectopic
pancreas, melanoma, gastrointestinal lymphoma,
and gastrointestinal stromal tumor in one each.
Capsule endoscopy for small bowel lesions
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Table 1. Demographic data, capsule endoscopy findings, and treatment
Patient Sex/age (yr) Indications Capsule endoscopy findings Treatment
1 M/39 GI bleeding Ileal tumor (lipoma) –
2 M/79 GI bleeding Terminal ileum tumor Outpatient follow-up
3 M/32 IDA Lymphangioma with Refer for double 
bleeding balloon enteroscopy
4 F/66 GI bleeding Suspect submucosal tumor –
5 M/54 GI bleeding Entrapped in the duodenal Operation
diverticulum, GIST
6 M/43 Physical check-up Lymphangioma –
7 M/38 GI bleeding Red polyp with a stalk in ileum Operation
8 M/23 GI bleeding Ruled out normal bulge of Refer for double 
upper ileum balloon enteroscopy
9 M/65 Melanoma Melanoma with Palliative C/T with 
work-up metastasis dacarbazine regimen
10 M/79 GI bleeding Nodular masses with whitish, CEOP C/T
lymphangiectatic, swollen 
villi over the proximal and 
distal small bowel
11 F/79 GI bleeding Suspect GIST –
12 M/67 GI bleeding Ruled out submucosal tumor Operation
of duodenum, diverticulosis 
of small bowel
GI = gastrointestinal; IDA = iron deficiency anemia; GIST = gastrointestinal stromal tumor; C/T = chemotherapy; CEOP = epirubicin
with cyclophosphamide, vincristine and prednisone.
Table 2. Features of scoring system for 12 patients with suspected mass lesions
Patient Bleeding MD IS Color WV Score
1 – – – + – 1
2 – – – – – 0
3 + + + + + 5
4 – + – – – 1
5 + + + + – 4
6 – + + + + 4
7 – + + + – 3
8 – – – – – 0
9 + + + + – 4
10 + + + + + 5
11 – + + – – 2
12 – + + – – 2
MD = mucosal disruption; IS = irregular surface; WV = white villi.
There was a low probability of small bowel mass
lesions in those with a score of ≤ 2 (Figure 2).
Discussion
Capsule endoscopy is a new technology that has
been developed to investigate diseases of the
small intestine. It has been shown to be superior
to current modalities such as small bowel bar-
ium radiology and push enteroscopy.5 Capsule
endoscopy, as a novel endoscopic procedure, has
led to reclassification of the terminology of gas-
trointestinal tract diseases.6,7
Small bowel tumors account for 3–6% of gas-
trointestinal tumors, and cancer of the small in-
testine represents < 2% of all malignant tumors
in the gastrointestinal tract.8 Prior to the advent
of capsule endoscopy, methods for examining
the small bowel proved inadequate, therefore, the
accuracy of the previous statement is unknown.
Small bowel tumors detected with capsule en-
doscopy are frequently revealed by obscure gas-
trointestinal bleeding; in our patients, the most
common presentation was obstruction and pain.
Our proposed tumor score was composed of
five components: bleeding, mucosal disruption,
an irregular surface, color, and white villi. Our
proposed criteria are based on the following ob-
servations. Benign and malignant small bowel
tumors cannot be reliably differentiated by cap-
sule endoscopy. The surface of benign tumors
such as hyperplasia, hamartoma, ectopic pan-
creas, and adenoma may show generally circum-
scribed ulceration. Vascular tumors often have a
reddish or bluish appearance. Capsule endoscopy
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Lymphangioma Ectopic pancreas
Melanoma meta Β-cell lymphoma
Figure 1. Probable small bowel
mass lesions.
of adenocarcinoma may reveal an infiltrating 
lesion that may show ulceration and/or bleed-
ing. Lymphoma may have different appearances.
Metastatic melanoma can often be suspected by
its pigmented nature, as shown in our study.
The patient with ileal ectopic pancreas had a
score of 3, which corresponded to intermediate
probability of a small bowel mass lesion. Early
studies have suggested that there is no significant
difference in the diagnostic yield of capsule endo-
scopy in obscure-overt and obscure-occult bleed-
ing, but in the study by Pennazio et al,9 patient
selection was paramount for optimal use of cap-
sule endoscopy. In patient 7, we suggest that if
capsule endoscopy had been done earlier, the
tumor score would have increased from 3 to 4 on
account of bleeding.
Neovascularization by angiogenesis occurs in
pathological settings such as tumor growth.10,11
In the present study, the increased accuracy of
capsule endoscopy was dependent on the defini-
tion that the authors used (red color) to define a
neoplasm. White villi were found in our patients
undergoing capsule endoscopy. They were most
likely to be primary lymphangiectasia, and were
a normal anatomical variant.12 Adult intestinal
lymphangiectasia is secondary to many other
factors, such as lymphoma, intestinal tuberculo-
sis, and adenocarcinoma.13 In the present study,
we could not predict pathology and tumor type
by using the scoring system.
The major point of interest of this study was
to detect the presence of small bowel tumors
using the scoring system. When diagnoses are
compared in a non-randomized study, as in ours,
scoring systems can sometimes help mitigate the
potential bias that arises from the lack of ran-
domization.14 One drawback of our research was
the relatively small number of patients and the
retrospective database, although it was constructed
correctly. Therefore, further, large prospective stud-
ies are needed to confirm our results.
In conclusion, we can determine criteria to in-
dicate the presence of a small bowel mass lesion
by capsule endoscopy, and reduce the false-positive
rate. High or intermediate probability lesions may
lead to double balloon enteroscopy or surgery,
while treatment of lesions with low probability
will depend on their clinical significance.
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